This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Humira
  • /
  • To Assess the Efficacy and Safety of Adalimumab in...
Clinical trial

To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa (HIDRI2007)

Read time: 2 mins
Last updated:1st Feb 2007
Identifier: NCT00827996
The trial is a 12-week phase 2 study. Subjects will be given subcutaneous injections at weeks 0 (160mg), 2 (80mg), and then every other week (40mg) until week 12 in subjects with moderate to severe hidradenitis suppurativa.
Category Value
Date last updated at source 2009-01-22
Study type(s) Interventional
Study start date 2007-02-01
Estimated primary completion date 2008-08-01

View full details